A rep runs a clean demo. The practice owner nods along, asks smart questions, says she needs to think about it. Two weeks pass. Nothing. The CRM gets marked "stalled, no urgency."
That note is wrong twice over. She has plenty of urgency, and the deal is still running. Just without the rep in the room.
"I need to think about it" is almost never about the product. The rep already answered the product questions: pricing, integrations, onboarding time. What she's actually doing is running a second evaluation nobody on your side gets to sit in on.
The demo answers the wrong evaluation
A sales demo is built to answer one question: does this software do what we need it to do? That's a fair question, and most vendors answer it well. Feature walkthroughs are polished. ROI calculators are ready. Objection-handling scripts cover price, contract length, data migration.
But a practice owner isn't buying software in isolation. She's buying a change her team has to live with starting Monday. That's a completely different evaluation, and it happens after the call ends, with people who never saw the demo.
Nobody built content for that evaluation. So she runs it alone, with worse information than she had in the room with you.
This is where most health tech pipelines actually leak. Not at the top, where marketing generates the demo request. Not at the bottom, where a signed contract gets processed. Right in the middle, in the gap between "great demo" and "still thinking," where nothing you wrote was built to help her.
Four conversations that happen after you leave
None of these show up in a sales call. All of them decide whether the deal closes.
Will the team actually use it, or quietly go back to the old system by Friday? She's watched this happen before. A new tool gets rolled out, the front desk finds it slower for the first two weeks, and by month two everyone's back to the spreadsheet they know. She isn't worried about whether the software works. She's worried about whether it survives contact with a Monday morning when three patients are late and the phone won't stop ringing.
What happens to patients mid-transition? Does a booking get lost. Does billing break for a stretch while the team learns the new system. Does a recall reminder go out twice, or not at all, during the changeover. She isn't asking this out loud because it makes her sound like she doesn't trust you. She's still asking it, usually at 11pm, alone.
Who loses standing if this goes in? Someone on staff owns the current system, informally or otherwise. Maybe it's the office manager who built the current scheduling workaround from scratch. Replacing it replaces part of that person's job, and possibly some of their authority in the practice. She has to manage that conversation, and you'll never be in the room for it.
What's the story if it doesn't work? If she's answering to a practice group, a partner, or just herself in six months, she needs a version of events where this was a reasonable call even if it goes sideways. Nobody hands her that story. She has to write it herself, usually somewhere between the demo and the decision, without much to draw on.
The quiet period is homework
Sales teams treat the quiet period as a signal to back off or escalate. Neither helps. She's running four conversations you can't see, with information she mostly has to invent.
She's talking to her office manager about workflow. She's guessing at how long retraining takes, because nobody gave her a real number. She's building a rollback plan in her head in case it doesn't stick, because nobody offered her one. Every one of those conversations goes better with something concrete to point to. Right now, most vendors give her nothing but a feature comparison PDF and a follow-up email asking if she's had a chance to review.
A follow-up email answers a question she didn't ask. It doesn't touch the four she's actually sitting with.
What content does that a call can't
A sales call has to happen live, with you present, at a scheduled time. Content doesn't. That's the advantage, and most vendors don't use it.
A piece on how a two-person front desk introduces new scheduling software without losing a week of productivity does more for that stalled deal than a follow-up call. It answers the question she's actually sitting with, and it lets her forward it to the person she's trying to convince without having to explain the product herself.
Same goes for a plain explanation of what a rollback looks like if the migration doesn't go cleanly. Most companies avoid writing this because it feels like advertising the possibility of failure. It's the opposite. A vendor willing to say "here's exactly what happens if this goes wrong, and here's how we'd fix it" reads as someone who's done this enough times to know.
A short piece on how other practices handled the "who loses ownership" conversation internally does something a demo never can: it gives her language for a conversation she has to run herself, with someone on her own team, days after your call ends.
Write for the meeting you're not in
Most health tech content is written for the buyer sitting across from the rep. It should be written for the four conversations that happen after that meeting ends, where nobody from your company is present to make the case.
That means fewer pieces titled "10 features of our platform" and more titled "how to roll out new practice software without losing your front desk for a week." One sells to a person you're already talking to. The other sells to the three people you're not, and it does it without you having to be in three places at once.
This is a pipeline problem
Every deal sitting in "stalled, no urgency" cost real time and budget to generate. Ads, outbound, a demo booked and delivered. The deal doesn't die when a practice owner goes quiet. It moves into a stage with no content built for it, so it drags for weeks longer than it should, or drops off the pipeline entirely because nobody addressed the actual objection.
Shortening that stage means having something ready for the exact moment she starts having conversations you can't be part of. Get that right, and the gap between demo and signature stops being dead time on the forecast.
If you're the one reporting pipeline numbers upward, this is also the stage most worth fixing first. It's usually the largest single group of deals sitting untouched in the CRM, and it's the one nobody has written anything for.
The math worth doing before your next content brief
Say a quarter of your demoed deals stall at exactly this point, for three or four extra weeks each, before they either close or die quietly. Multiply that delay across a full quarter of demos and it adds up to a meaningful chunk of pipeline sitting in limbo for no reason tied to the product.
Compare that to what it costs to write four pieces addressing the four conversations above. The content is cheaper than the ad spend that generated those demos in the first place, and it works on every deal that stalls the same way going forward, not just the one you're chasing this week.
That's the case for prioritizing this stage over another top-of-funnel article. Top-of-funnel content brings in the next fifty demos. This content decides how many of the fifty you already have actually close.
Where to find this in your own pipeline
Pull every deal marked "stalled" or "no response" that had at least one completed demo. Sort by days since last activity. That list is a map of exactly where your content is missing, not a list of lost causes.
Ask whoever ran each demo what came up in the call: staffing concerns, a specific team member's resistance, a past bad experience with a switch. Those answers, collected across ten or twenty deals, tell you which of the four conversations is actually killing your pipeline. Write to that one first.
What good looks like in a content brief
Once you know which conversation is stalling deals, the brief writes itself. Four examples, one per conversation:
- "How a two-person front desk switches scheduling software without losing a week" answers the adoption fear directly, with a timeline instead of a promise.
- "What happens to appointments and billing during a two-week migration, step by step" answers the patient-disruption question before she has to ask it.
- "How to bring your office manager into a software decision without making it feel like a demotion" gives her language for the internal conversation she's dreading.
- "What we do in the first 48 hours if a migration doesn't go to plan" answers the failure question head-on, and does more for trust than another testimonial.
None of these read like marketing. They read like the notes a smart operator would hand a friend who was about to make the same decision. That's the point.
Start with the objection that never gets said
Ask your sales team what "I need to think about it" usually turns into, three weeks later, when a deal actually dies. It's rarely price. It's almost always one of the four conversations above, unresolved, with nothing written to help her win it.
Build content around those four conversations first. The features a demo already covers well don't need another article. This is the gap between a good demo and a closed deal, and it's sitting wide open in most health tech content plans.